Our recent experimental findings indicate a notably elevated expression level of CX3CR1 in the T2DM combined MAFLD group compared to the control group in RT-PCR and immunohistochemistry experiments. This evidence concerns the gene CX3CR1 and type 2 diabetes mellitus.